Join the Editorial Board | Coronaviruses

 

Coronaviruses-join-editorial-board

 

JOIN EDITORIAL BOARD FOR THE  JOURNAL

CORONAVIRUSES 

“NEW IN 2020”

 

Bentham Science is interested in appointing active Editorial Board Members for  the journal; Coronaviruses. If you are working in the related field of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications. You can also recommend suitable colleagues for the same, and, if possible, send their CV along with their list of publications. 

 

Mention in the subject line the field of interest, and send your CV at: beena@benthamscience.net and hermain@benthamscience.net

CC: faizan@benthamscience.net

 

AIMS & SCOPE

Coronaviruses publishes original research articles, letters, reviews/mini-reviews, clinical trial and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc.

The Journal also covers case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment and development of new therapeutics.

To know more about the journal, please visit: https://benthamscience.com/journals/coronaviruses/

Become a Reviewer | Current Alzheimer Research

 

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

The Journal Current Alzheimer Research is interested in appointing active Reviewer  on the Journal’s Board. If you are working in the related field as of the journal and are interested in becoming an Reviewer, please send us your CV and a list of publications. If, however, the scope of the journal is not directly related to your field, you can recommend suitable colleagues for the same, and, if possible, send their CV along with their list of publications. Mention in the subject line, the field of interest and send your CV at:

 

Wordpress - Reviewer.jpg

Become an Editorial Board Member (EBM) | Current Alzheimer Research

 

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

The Journal Current Alzheimer Research is interested in appointing active Editorial Board Member  on the Journal’s Board. If you are working in the related field as of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications. If, however, the scope of the journal is not directly related to your field, you can recommend suitable colleagues for the same, and, if possible, send their CV along with their list of publications. Mention in the subject line, the field of interest and send your CV at:

 

Wordpress.jpg

Become a Reviewer | Current Alzheimer Research

 

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

The Journal Current Alzheimer Research is interested in appointing active Reviewer  on the Journal’s Board. If you are working in the related field as of the journal and are interested in becoming an Reviewer, please send us your CV and a list of publications. If, however, the scope of the journal is not directly related to your field, you can recommend suitable colleagues for the same, and, if possible, send their CV along with their list of publications. Mention in the subject line, the field of interest and send your CV at:

 

Wordpress - Reviewer.jpg

Become an Editorial Board Member (EBM) | Current Alzheimer Research

 

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

The Journal Current Alzheimer Research is interested in appointing active Editorial Board Member  on the Journal’s Board. If you are working in the related field as of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications. If, however, the scope of the journal is not directly related to your field, you can recommend suitable colleagues for the same, and, if possible, send their CV along with their list of publications. Mention in the subject line, the field of interest and send your CV at:

 

Wordpress.jpg

Become a Reviewer | Current Alzheimer Research (CAR)

 

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

 

Abstracted and Indexed in:

  • Science Citation Index-Expanded
  • Journal Citation Reports/Science Edition
  • InCites
  • Neuroscience Citation Index
  • Current Contents® – Life Sciences
  • Current Contents® – Clinical Medicine
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE
  • Chemical Abstracts Service/SciFinder
  • PsycINFO
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • EMNursing
  • EMCare
  • Alzforum
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • PubsHub
  • Index Copernicus
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

 

The Journal is interested in appointing active Reviewers on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming a Reviewer, send us your CV at the below mentioned email. If, however, the scope of the journal is not directly related to your field of interest then please feel free to recommend suitable colleagues for the Reviewers of the journal and, if possible, send us their CV mentioning the field of interest.

 

Please submit the CV at your earliest convenience at hermain@benthamscience.netand CC faizan@benthamscience.net, mentioning in the subject line your field of interest. The responsibilities of Reviewers will be discussed in detail further once the CV is received.

 

reviewer-banner-

Become an Editorial Board Member (EBM) | Current Alzheimer Research (CAR)

 

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

 

Abstracted and Indexed in:

  • Science Citation Index-Expanded
  • Journal Citation Reports/Science Edition
  • InCites
  • Neuroscience Citation Index
  • Current Contents® – Life Sciences
  • Current Contents® – Clinical Medicine
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE
  • Chemical Abstracts Service/SciFinder
  • PsycINFO
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • EMNursing
  • EMCare
  • Alzforum
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • PubsHub
  • Index Copernicus
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

 

The Journal is interested in appointing active Editorial Board Members on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications to the email mentioned below. If, however, the scope of the journal is not directly related to your field of interest then please feel free to recommend suitable colleagues for the Editorial Board membership of the journal and, if possible, send us their CV along with their list of publications.

 

Please submit the CV at your earliest convenience at hermain@benthamscience.netand CC faizan@benthamscience.net, mentioning in the subject line your field of interest. The responsibilities of Editorial Board Members will be discussed in detail further once the CV is received.

 

banner

MOST ACCESSED ARTICLE – Mesenchymal Stem Cells-Derived Exosomes: A Possible Therapeutic Strategy for Osteoporosis

Journal Name: Current Stem Cell Research & Therapy

Author(s): Yue Li, Daxiang Jin*, Weixing Xie, Longfei Wen, Weijian Chen, Jixi Xu, Jinyong Ding, Dongcheng Ren, Zenglin Xiao.

 

 

 

Abstract:

Osteoporosis is a common age-related disorder characterized by low bone mass and deterioration in bone microarchitecture, leading to increased skeletal fragility and fracture risk. The pathophysiology of osteoporosis is multifactorial. It is related to the imbalance between osteoblasts and osteoclasts; reduced bone mass and increased adipogenesis in the bone marrow. Moreover, angiogenesis, inflammatory process and miRNAs have shown effects in the formation of osteoporosis. In the recent years, mesenchymal stem cells (MSCs) have been regarded as an excellent choice for cell-based tissue engineering therapy of osteoporosis. Growing evidence showed that paracrine effect has been considered as the predominant mechanism for the role of MSCs in tissue repair. Recently, many studies have proposed that MSCs-derived exosomes are effective for a variety of diseases like cancer, cardiovascular diseases, etc. However, whether the MSCs-derived exosomes could serve as a novel therapeutic tool for osteoporosis has not clearly described. In this review, we summarize the MSCs-derived exosomes and the relationship with osteogenesis, osteoclast differentiation, angiogenesis, immune processes and miRNAs. Finally, we suggest that MSCs-derived exosomes might be a promising therapeutic method for osteoporosis in the future.

 

For more details, please visit: http://www.eurekaselect.com/160963

EDITOR’S CHOICE – Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants – Current Drug Targets

Journal: Current Drug Targets

Author(s): Gurdyal Singh, Arbind Kumar, Pratibha Maan, Jagdeep Kaur

Graphical Abstract:

Abstract:

Background: Mycobacteria genus is responsible for deadly diseases like tuberculosis and leprosy. Cell wall of bacteria belonging to this genus is unique in many ways. It plays a major role in the pathogenesis and intracellular survival inside the host. In intracellular pathogens, their cell wall acts as molecular shield and interacts with host cell milieu to modulate host defense responses.

Objectives: In this review, we summarize the factors that participate in the biosynthesis of unique mycobacterial cell wall, understand their potential as drug targets and the recent developments where they have been evaluated as possible drug targets.

Results: Several cell wall associated factors that play crucial roles in the synthesis of cell wall components like Antigen 85 complex, Glycosyltransferases (GTs), LM (lipomannan) and LAM (lipoarabinomannan), mAGP Complex, lipolytic enzyme have been categorically documented. Most of the presently used anti TB regimens interrupted cell wall synthesis, but the emergence of drug resistant strains made it mandatory to identify new drug targets. Novel drug candidates which could inhibit the synthesis of cell wall components have been thoroughly studied worldwide.

Conclusion: Studies demonstrated that the cell wall components are unique in terms of their contribution in mycobacterium pathogenesis. Targeting these can hamper the growth of M. tuberculosis. In this study, we scrutinize the drugs under trials and the potential candidates screened through in silico findings.

 

To access the article, please visit: http://www.eurekaselect.com/154134

Olive Oil and Apoptosis of Cancer Cells

Current Nutrition & Food Science, 6(4): 227-232.

Author(s): Nadia Sabatini and Enzo Perri.

Abstract: Olive oil, the major source of mono-unsaturated fatty acids in the Mediterranean basin, appears to be protective against various human diseases including cancer. Recent studies have reported that major and minor components of olive oil can significantly counteract carcinogenesis in mutant cells by activating specific metabolic pathways involved in the apoptosis.

11-20-2015 3-27-58 PM

http://bit.ly/1S8jzQb

 

%d bloggers like this: